Vitamin B9

1. What conditions has Vitamin B9 been studied for?

• Neural tube defects (NTDs) in pregnancy: Studied extensively for primary prevention of NTDs; folate insufficiency before and early in pregnancy is described as the most common preventable risk factor.

• Folate deficiency states and megaloblastic anemia: Folate deficiency is linked to megaloblastic anemia; supplementation is discussed, including the important caveat of vitamin B12 deficiency masking.

• Genomic instability and DNA damage-related outcomes: Folate deficiency has been studied for effects on chromosome breaks, fragile sites, uracil misincorporation into DNA, micronucleus formation, DNA hypomethylation, mitochondrial DNA deletions, and telomere length (often alongside vitamin B12 and homocysteine status).

• Homocysteine metabolism / one-carbon metabolism: Folate (especially as 5-MTHF) is described as a methyl donor involved in converting homocysteine to methionine.

• Cancer risk (folate-sensitive cancers, e.g., colorectal cancer): Excess synthetic folic acid intake is discussed as a concern for potentially promoting carcinogenesis and folate-sensitive cancers.

• Pregnancy and offspring outcomes beyond NTDs: Excess folate/folic acid is discussed in relation to embryogenesis, pregnancy outcomes, neurodevelopment, and potential transgenerational epigenetic effects (mechanistic/associative concerns highlighted in a review).

• Type 2 diabetes context (metformin-associated nutrient issues): In people using metformin long-term, folate (and B12) supplementation is discussed due to reduced absorption of these nutrients.

• Interactions with antifolate antimalarials in pregnancy/infancy: Folate status and supplementation are discussed in the context of sulfadoxine/pyrimethamine (an antifolate) used for intermittent preventive treatment in pregnancy/infants.

• Veterinary reproduction (canine semen quality): A dog study investigated a multi-micronutrient supplement including folic acid for semen motility and membrane properties (folic acid was part of a combination, not isolated).

• Stability/degradation considerations for therapeutic/diagnostic uses: Folic acid degradation has been studied (light, temperature, oxygen, pH, concentration; plus singlet oxygen and electron beam in some technologies).

2. Does it work in treating those conditions? Summarize the evidence.

• Prevention of neural tube defects (strong evidence of benefit):

  • A review states maternal folate insufficiency before and during early pregnancy is the most common risk factor and is preventable, and that folic acid is required for neural tube formation around ~28 days after conception.

  • Guidelines cited in the abstracts recommend 400–800 μg/day folic acid for women planning or capable of pregnancy.

  • Mandatory folic acid fortification of staple foods is described as safe, economical, and effective for primary prevention; post-fortification data are described as providing strong evidence for reduced NTDs.

• Correcting folate deficiency / megaloblastic anemia (effective, but with an important limitation):

  • Folate deficiency is linked to megaloblastic anemia; supplementation addresses deficiency, but one abstract emphasizes that folic acid can conceal (mask) megaloblastic anemia due to vitamin B12 deficiency, which can delay diagnosis/treatment of B12 deficiency.

• Reducing genomic instability markers (supportive mechanistic + intervention threshold evidence):

  • In vitro and in vivo human-cell evidence summarized in one abstract indicates folate deficiency causes chromosome breaks, fragile site expression, uracil incorporation, micronuclei, and DNA hypomethylation.

  • Human intervention evidence summarized suggests these outcomes are minimized when red cell folate >700 nmol/L; and that adequate vitamin B12 (>300 pmol/L) and low homocysteine (<7.5 μmol/L) are also important.

  • The abstract notes these biomarker targets are achievable at intake levels at or above recommended intakes (e.g., >400 μg/day folate and >2 μg/day vitamin B12), depending on absorption/metabolism.

• Homocysteine metabolism (biochemical role; clinical outcomes not established in these abstracts):

  • 5-MTHF is described as a methyl donor for conversion of homocysteine to methionine, but the provided abstracts do not give clinical endpoint trials (e.g., cardiovascular outcomes) demonstrating benefit.

• Cancer prevention or treatment (insufficient/concern-leaning evidence in these abstracts):

  • The abstracts raise concerns that excess folic acid intake may promote carcinogenesis and folate-sensitive cancers (including colorectal cancer), but do not provide definitive causal trial evidence in the text provided.

• Metformin users with type 2 diabetes (rationale for supplementation; outcome evidence not established here):

  • A review notes metformin can limit absorption of vitamin B9 and B12 and suggests long-term users may benefit from additional supplementation; however, it also states evidence is inconsistent and there are no clear guidelines for vitamin supplementation in type 2 diabetes overall.

• Canine sub-fertility (unclear efficacy from provided text):

  • A small dog study investigated a combination supplement including folic acid; because folic acid was not isolated and results are not shown in the provided excerpt, efficacy cannot be concluded from these abstracts alone.

3. What health benefits does it have?

• Prevents neural tube defects when adequate before and very early in pregnancy: The abstracts emphasize folic acid is required for neural tube formation and that supplementation/fortification reduces NTD prevalence.

• Supports DNA synthesis, repair, and methylation (one-carbon metabolism): Folate’s role in the one-carbon cycle is highlighted, including DNA precursor biosynthesis and methylation reactions.

• Supports normal cell division and growth (especially embryonic/fetal growth): One abstract notes folate is fundamental for growth, particularly in embryonic and fetal stages.

• Helps maintain genomic stability under adequate status: Evidence summarized indicates folate sufficiency reduces uracil misincorporation into DNA, chromosome breaks, micronucleus formation, and DNA hypomethylation (with adequate B12 also being important).

• Supports homocysteine-to-methionine conversion: 5-MTHF is described as a methyl donor in the conversion of homocysteine into methionine.

4. Does it have any downsides or side effects?

• Potential harms of excess intake (especially synthetic folic acid):

  • A review highlights concerns that excessive folate/folic acid intake may have deleterious effects, including potential increased risk of carcinogenesis, disruption of DNA methylation, and possible impacts on embryogenesis, pregnancy outcomes, and neurodevelopment; it also raises the possibility of transgenerational epigenetic effects. These are presented as concerns requiring further research rather than settled conclusions.

  • Another abstract notes concern about high synthetic folic acid exposure in fortified food supplies and links excess folic acid intake to masking vitamin B12 deficiency and concerns about promotion of folate-sensitive cancers (including colorectal cancer).

• Masking vitamin B12 deficiency:

  • One abstract explicitly warns that folic acid can conceal megaloblastic anemia due to vitamin B12 deficiency, potentially delaying recognition of B12 deficiency.

  • Another abstract emphasizes that genomic instability outcomes are minimized not only with adequate folate but also with adequate vitamin B12 and low homocysteine, underscoring the importance of B12 status when supplementing folate.

• Unmetabolized folic acid accumulation in some people:

  • A review comparing folic acid vs 5-MTHF notes folic acid must be converted in the liver to active 5-MTHF and may accumulate in blood when hepatic transformation is reduced (e.g., genetic variants or some pharmacotherapies). It suggests 5-MTHF may avoid some of these issues.

• Product stability issues (quality/handling rather than a biological side effect):

  • Folic acid can degrade depending on light, temperature, oxygen, pH, and concentration (and in some contexts singlet oxygen/electron beam). This can affect potency in formulations and research/therapeutic applications.

5. Is it beneficial or harmful for any genetic variations (pharmacogenomics)?

• Reduced folic acid activation due to genetic variants (potentially relevant):

  • One abstract states folic acid is inactive and must be converted by the liver to 5-MTHF, and that risks may arise in cases of reduced hepatic transformation “due to genetic variants” (not specified in the abstract). In such cases, 5-MTHF supplementation is proposed as potentially advantageous because it does not require activation and is immediately available.

• Inter-individual variability in absorption/metabolism (genetic/epigenetic):

  • The genomic instability abstract notes that achieving protective folate/B12 status depends on an individual’s capacity to absorb and metabolize these vitamins, which may vary due to genetic and epigenetic differences. Specific variants are not named in the provided text.

• Practical implication:

  • Based on these abstracts, pharmacogenomic concerns center on whether someone efficiently converts folic acid to 5-MTHF and whether unmetabolized folic acid accumulates; in such scenarios, using 5-MTHF instead of folic acid is presented as a strategy to reduce risk, though the abstracts call for further research on optimal intake and mechanisms.

References

1. Neural tube defects: a review of global prevalence, causes, and primary prevention.
   Vijaya Kancherla (2023) - Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery
2. Uncovering the Hidden Dangers and Molecular Mechanisms of Excess Folate: A Narrative Review.
   Ali M Fardous, Ahmad R Heydari (2023) - Nutrients
3. Recent Progress in Folic Acid Detection Based on Fluorescent Carbon Dots as Sensors: A Review.
   Kawan F Kayani, Mohammed K Rahim, Sewara J Mohammed, Harez Rashid Ahmed, Muhammad S Mustafa, Shujahadeen B Aziz (2025) - Journal of fluorescence
4. Folate (vitamin B9) and vitamin B12 and their function in the maintenance of nuclear and mitochondrial genome integrity.
   Michael Fenech (2012) - Mutation research
5. Stability of folic acid under several parameters.
   Amirah Mohd Gazzali, Mathilde Lobry, Ludovic Colombeau, Samir Acherar, Henri Azaïs, Serge Mordon, Philippe Arnoux, Francis Baros, Régis Vanderesse, Céline Frochot (2016) - European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
6. Folic acid versus 5- methyl tetrahydrofolate supplementation in pregnancy.
   Enrico Ferrazzi, Giulia Tiso, Daniela Di Martino (2020) - European journal of obstetrics, gynecology, and reproductive biology
7. Nitrous oxide abuse direct measurement for diagnosis and follow-up: update on kinetics and impact on metabolic pathways.
   Angèle Lucas, Alastair J Noyce, Emeline Gernez, Joe M El Khoury, Guillaume Garcon, Etienne Cavalier, Sébastien Antherieu, Guillaume Grzych (2024) - Clinical chemistry and laboratory medicine
8. Recent Developments in Folate Nutrition.
   Nassim Naderi, James D House (2018) - Advances in food and nutrition research
9. The Effect of Dietary Supplementation of Vitamin E, Selenium, Zinc, Folic Acid, and N-3 Polyunsaturated Fatty Acids on Sperm Motility and Membrane Properties in Dogs.
   Salvatore Alonge, Monica Melandri, Raffaella Leoci, Giovanni M Lacalandra, Michele Caira, Giulio G Aiudi (2019) - Animals : an open access journal from MDPI
10. Relationship Between Vitamins and Diabetes.
    Devanshu S Raghuvanshi, Swarupa Chakole, Mayank Kumar (2023) - Cureus
11. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Krista Crider, Jennifer Williams, Yan Ping Qi, Julie Gutman, Lorraine Yeung, Cara Mai, Julia Finkelstain, Saurabh Mehta, Clara Pons-Duran, Clara Menéndez, Cinta Moraleda, Lisa Rogers, Kelicia Daniels, Patricia Green (2022) - The Cochrane database of systematic reviews
12. Diet-Induced Severe Hyperhomocysteinemia Promotes Atherosclerosis Progression and Dysregulates the Plasma Metabolome in Apolipoprotein-E-Deficient Mice.
    Stephen G Andrews, Anthony M Koehle, Devendra Paudel, Thomas Neuberger, A Catharine Ross, Vishal Singh, Teodoro Bottiglieri, Rita Castro (2024) - Nutrients
13. Are Dietary Supplements and Nutraceuticals Effective for Musculoskeletal Health and Cognitive Function? A Scoping Review.
    G Iolascon, R Gimigliano, M Bianco, A De Sire, A Moretti, A Giusti, N Malavolta, S Migliaccio, A Migliore, N Napoli, P Piscitelli, G Resmini, U Tarantino, F Gimigliano (2017) - The journal of nutrition, health & aging
14. Supplementation with Folic Acid or 5-Methyltetrahydrofolate and Prevention of Neural Tube Defects: An Evidence-Based Narrative Review
    María de Lourdes Samaniego-Vaesken, Carmen Morais-Moreno, Alejandra Carretero-Krug, Ana María Puga, Ana María Montero-Bravo (2024)
15. Riboflavin-Targeted Drug Delivery.
    Milita Darguzyte, Natascha Drude, Twan Lammers, Fabian Kiessling (2020) - Cancers
16. The link between homocysteine, folic acid and vitamin B12 in chronic kidney disease.
    Andrea Angelini, Maria Laura Cappuccilli, Giacomo Magnoni, Anna Laura Croci Chiocchini, Valeria Aiello, Angelo Napoletano, Francesca Iacovella, Antonella Troiano, Raul Mancini, Irene Capelli, Giuseppe Cianciolo (2021) - Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia
17. Folate and B12 Levels Correlate with Histological Severity in NASH Patients.
    Mahmud Mahamid, Naim Mahroum, Nicola Luigi Bragazzi, Kasem Shalaata, Yarden Yavne, Mohammad Adawi, Howard Amital, Abdulla Watad (2018) - Nutrients
18. Negative effects of endocrine disruptor bisphenol A on ovarian granulosa cells and the protective role of folic acid.
    Dominika Celar Sturm, Irma Virant-Klun (2023) - Reproduction (Cambridge, England)
19. Anti-Tumor Effects of Vitamin B2, B6 and B9 in Promonocytic Lymphoma Cells.
    Kathleen Mikkelsen, Monica D Prakash, Nyanbol Kuol, Kulmira Nurgali, Lily Stojanovska, Vasso Apostolopoulos (2019) - International journal of molecular sciences
20. Simplifying the B Complex: How Vitamins B6 and B9 Modulate One Carbon Metabolism in Cancer and Beyond.
    Carolina N Franco, Laurence J Seabrook, Steven T Nguyen, Jack T Leonard, Lauren V Albrecht (2022) - Metabolites